Page 8 of 8 FirstFirst 12345678
Results 71 to 76 of 76

Thread: Dr Martin Schwab - Switzerland.

  1. #71
    Senior Member
    Join Date
    May 2005
    Location
    Pakistan
    Posts
    1,177
    Quote Originally Posted by Jawaid View Post
    Jerry are neural stem cells same which StemCell Inc is using and Neuralstem will be using for phase one with chronic injuries soon as they have applied with FDA?

    Also www.stemedics.com have shown good results with animals with their neural cells. So are these same neural stem cells or some difference?

    Is it true that through IV or spinal fluid injection stem cells dont reach injury site in chronic injuries than direct injections at injury site in and around? What is the best method to go with?
    Are lumbar injuries hard to treat than cervical and thoracic injuries or may be easier?
    Sorry it is www.stemedica.com

  2. #72

  3. #73
    Super Moderator Sue Pendleton's Avatar
    Join Date
    Jul 2001
    Location
    Wisconsin USA
    Posts
    11,007
    Nice layout of the phases of trials, fti.
    Courage doesn't always roar. Sometimes courage is the quiet voice at the end of the day saying, "I will try again tomorrow."

    Disclaimer: Answers, suggestions, and/or comments do not constitute medical advice expressed or implied and are based solely on my experiences as a SCI patient. Please consult your attending physician for medical advise and treatment. In the event of a medical emergency please call 911.

  4. #74



    Dear Patrick,

    I am contacting you with regard to your interest in the Nogo-A antibody therapy in spinal cord injured patients.

    We performed a phase I safety study which was completed in 2011. You will find more information about this study at: https://clinicaltrials.gov/ct2/show/NCT00406016

    We plan to perform a multicenter European clinical phase II study and are currently applying for funding resources. If we receive the resources the study might start at the end of 2015. In the planned study only fresh spinal cord injuries (1-2 months after injury) will be addressed, because we assume that the treatment is most efficient in these patients.

    Let me know in case you should have any additional questions.

    Kind regards,
    Christina Sina



    -----
    Dr. Christina Sina
    Scientific Coordinator Schwab Group

    Brain Research Institute
    University of Zurich
    Winterthurerstrasse 190
    CH-8057 Zurich
    Switzerland

    Email: sina@hifo.uzh.ch
    Phone: +41-44-63-53262
    JustaDollarPlease.org

  5. #75
    Was there any functional improvement in the phase 1 study?

  6. #76

Similar Threads

  1. Go for Novartis Nogo trial
    By wilfried in forum Cure
    Replies: 17
    Last Post: 06-28-2005, 02:40 PM
  2. Replies: 15
    Last Post: 07-17-2004, 12:02 PM
  3. Replies: 5
    Last Post: 11-29-2003, 08:06 PM
  4. Martin just keeps racing and winning
    By Max in forum Recreation, Sports, Travel, & Hobbies
    Replies: 0
    Last Post: 05-02-2003, 12:58 PM

Tags for this Thread

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •